Searched for
LUPIN PROFIT INCREASE
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- More women CXOs join India’s million-dollar pay club as domestic firms lead compensation growthNine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Suryoday Small Finance Bank reports Q4 profit at Rs 49 croreSuryoday Small Finance Bank reported a strong turnaround in fourth-quarter earnings with improved profitability and higher operating profit...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Stocks in news: HDFC Bank, ICICI Bank, RIL, Trent, Jio FinancialIndian markets are set for a dynamic start today. Investors will closely watch the Q4 results from banking giants HDFC Bank and ICICI Bank....
- Lupin shares drop 3% after Q3 resultsShares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged 102.7%, reach...
- Lupin looks to sell Japanese arm Kyowa for $600 millionKyowa grew a modest 5% over the year-ago level. Its net profit halved to Rs 68.6 crore constituting 11.3% of Lupin’s consolidated profit. "...
- US show a plus for Cipla, Lupin confident of recoveryThe domestic business grew 6 per cent, showing the impact of a high base effect.
- Buy Lupin, target Rs 985: HDFC SecuritiesBuy Lupin at a price target of Rs 985.
- Stock pick of the week: Why analysts are bullish on LupinIn addition to growth in sales in respective markets, favourable currency movement has also helped Lupin to achieve high growth.
- Lupin CFO says $1 billion M&A warchest may be just the startAs of September, the company had about $152 million in cash, and in its most recent earnings conference call said it had about $810 million...
- Brokerages bullish on Lupin post Q2 results; raise target priceThe company reported a 55 per cent jump in net profit at Rs 630 crore. It had reported a net profit of Rs 406 crore in the corresponding qu...
- Lupin Q1 net up 56 per cent on higher US drug salesLupin Managing Director Nilesh Gupta said: "Business is at an all time high with record revenues and profits driven by strong growth in the...
- Lupin shares gain 4.5% on rise in net profit, acquisitionShares of drug major Lupin gained 4.5 per cent today after its third-quarter profit rose and the company announced an acquisition.
- Lupin Q1 net up 43 per cent at Rs 401 croreThe company had posted a profit of Rs 280.4 crore during the same period in the previous fiscal.
- Lupin Q4 surges nearly three-fold to Rs 408 croreLupin Ltd posted nearly three-fold increase in its consolidated net profit at Rs 408.1 crore for the fourth quarter ended March 31, 2013.
- Inorganic engine drives Lupin’s generic growthMumbai-based Lupin has been aggressively using the inorganic route to expand its cross-border generic business.
- Lupin Q3 net up 27 pc at Rs 56 crPharmaceutical major Lupin Ltd on Wednesday posted a 26.79 per cent increase in net profit at Rs 56.03 crore for the quarter ended December...
Load More
